Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.
Bibliographical noteFunding Information:
Philipp Maisch received salary support as a Cochrane Urology Fellow through the Deutsche Forschungs GemeinschaC (DFG)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.